AAMU
KRRO icon

Amundi Asset Management US’s Korro Bio KRRO Stock Holding History

Amundi Asset Management US’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$1.9M Buy
+4,000
New +$7.77M ﹤0.01% 1192

Other funds holding KRRO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $23.5B AUM 33.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Amundi Asset Management US's KRRO Position: Q1 2021 in Review

Amundi Asset Management US opened a new position in Korro Bio (KRRO) in Q1 2021: 4,000 shares worth $1.9M. The stake represents ﹤0.01% of the portfolio and ranks #1192 among its holdings.

115 funds tracked by Wall St. Rank hold KRRO as of Q1 2021.

  • Amundi Asset Management US held 4,000 shares of Korro Bio worth $1.9M as of Q1 2021.
  • Korro Bio was a new Amundi Asset Management US position in Q1 2021.
  • Korro Bio made up ﹤0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #1192 holding.
  • 115 funds tracked by Wall St. Rank held Korro Bio as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.